Seigne J - Search Results

1

Enhanced tumor suppressor gene therapy via replication-deficient adenovirus vectors expressing an N-terminal truncated retinoblastoma protein.

Xu HJ, Zhou Y, Seigne J, Perng GS, Mixon M, Zhang C, Li J, Benedict WF, Hu SX. Xu HJ, et al. Among authors: seigne j. Cancer Res. 1996 May 15;56(10):2245-9. Cancer Res. 1996. PMID: 8625292

2

Expression of the retinoblastoma (RB) tumor suppressor gene inhibits tumor cell invasion in vitro.

Li J, Hu SX, Perng GS, Zhou Y, Xu K, Zhang C, Seigne J, Benedict WF, Xu HJ. Li J, et al. Among authors: seigne j. Oncogene. 1996 Dec 5;13(11):2379-86. Oncogene. 1996. PMID: 8957079

3

Constitutive activation of Stat3 in human prostate tumors and cell lines: direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells.

Mora LB, Buettner R, Seigne J, Diaz J, Ahmad N, Garcia R, Bowman T, Falcone R, Fairclough R, Cantor A, Muro-Cacho C, Livingston S, Karras J, Pow-Sang J, Jove R. Mora LB, et al. Among authors: seigne j. Cancer Res. 2002 Nov 15;62(22):6659-66. Cancer Res. 2002. PMID: 12438264

4

Contemporary management of superficial bladder cancer.

Pow-Sang JM, Seigne JD. Pow-Sang JM, et al. Among authors: seigne jd. Cancer Control. 2000 Jul-Aug;7(4):335-9. doi: 10.1177/107327480000700402. Cancer Control. 2000. PMID: 10895127 Free article. Review.

5

Bladder cancer. Clinical practice guidelines in oncology.

Montie JE, Bahnson RR, Cohen SM, Drucker B, Eisenberger MA, El-Galley R, Herr HW, Hudes GR, Kuzel TM, Lange PH, Patterson A, Pollack A, Richie JP, Seigne J, Shipley WU, Small EJ, Trump DL, Walther PJ, Wilson TG; National Comprehensive Cancer Network. Montie JE, et al. Among authors: seigne j. J Natl Compr Canc Netw. 2005 Jan;3(1):4-5, 19-34. J Natl Compr Canc Netw. 2005. PMID: 19813320

6

Characteristics of invasive bladder cancers: histological and molecular markers.

Liebert M, Seigne J. Liebert M, et al. Among authors: seigne j. Semin Urol Oncol. 1996 May;14(2):62-72. Semin Urol Oncol. 1996. PMID: 8734733 Review.

7

B7-1 gene-modified autologous tumor-cell vaccines for renal-cell carcinoma.

Antonia SJ, Seigne JD. Antonia SJ, et al. Among authors: seigne jd. World J Urol. 2000 Apr;18(2):157-63. doi: 10.1007/s003450050190. World J Urol. 2000. PMID: 10854153 Review.

8

Prostate adenocarcinoma: cellular and molecular abnormalities.

Mora LB, Buettner R, Ahmad N, Bassel Y, Jove R, Seigne JD. Mora LB, et al. Among authors: seigne jd. Cancer Control. 2001 Nov-Dec;8(6):551-61. doi: 10.1177/107327480100800612. Cancer Control. 2001. PMID: 11807425 Free article. Review. No abstract available.

9

The impact of frequent cystoscopy on surgical care and cancer outcomes among patients with low-risk, non-muscle-invasive bladder cancer.

Schroeck FR, Lynch KE, Li Z, MacKenzie TA, Han DS, Seigne JD, Robertson DJ, Sirovich B, Goodney PP. Schroeck FR, et al. Among authors: seigne jd. Cancer. 2019 Sep 15;125(18):3147-3154. doi: 10.1002/cncr.32185. Epub 2019 May 23. Cancer. 2019. PMID: 31120559 Free PMC article.

10

Reply by the authors.

Jarow J, Kluetz PG, Lerner SP, Liu K, Sridhara R, Bajorin D, Chang S, Dinney CP, Groshen S, Morton RA, O'Donnell M, Quale DZ, Schoenberg M, Seigne J, Vikram B. Jarow J, et al. Among authors: seigne j. Urology. 2014 Aug;84(2):495-6. doi: 10.1016/j.urology.2014.04.004. Urology. 2014. PMID: 25065996 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

108 results

Search Page